Srinivas K. Tantravahi

BCR-ABL1 Compound Mutations Combining Key Kinase Domain Positions Confer Clinical Resistance to Ponatinib in Ph Chromosome-Positive Leukemia

Matthew S. Zabriskie, Christopher A. Eide, Srinivas K. Tantravahi et al. · Cancer Cell · 2014 · 363 citations · Full text

Hematological Malignancy, Ph Chromosome-positive Leukemia, Genetics +7

Impact of Bone and Liver Metastases on Patients with Renal Cell Carcinoma Treated with Targeted Therapy

Rana R. McKay, Nils Kroeger, Wanling Xie et al. · European Urology · 2013 · 250 citations · Full text

Urology, Surgical Oncology, Genitourinary Cancer +7

Age-related mutations and chronic myelomonocytic leukemia

Clinton C. Mason, Jamshid S. Khorashad, Srinivas K. Tantravahi et al. · Leukemia · 2015 · 138 citations · Full text

Hematological Malignancy, Chromatin, Medicine +6

Combined STAT3 and BCR-ABL1 inhibition induces synthetic lethality in therapy-resistant chronic myeloid leukemia

Anna M. Eiring, Brent D. G. Page, Ira L. Kraft et al. · Leukemia · 2014 · 132 citations · Full text

Hematological Malignancy, Medicine, Mixed-phenotype Acute Leukemia +8

Chronic Myeloid Leukemia, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology

Neil P. Shah, Ravi Bhatia, Jessica K. Altman et al. · Journal of the National Comprehensive Cancer Network · 2024 · 96 citations · Full text